Tabula Rasa HealthCare (TRHC) PT Raised to $91.00 at Chardan Capital

Share on StockTwits

Tabula Rasa HealthCare (NASDAQ:TRHC) had its price objective upped by Chardan Capital from $77.00 to $91.00 in a report published on Wednesday. They currently have a buy rating on the stock.

A number of other equities research analysts also recently weighed in on the stock. Robert W. Baird boosted their price target on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the stock an outperform rating in a research note on Wednesday, September 19th. Cantor Fitzgerald initiated coverage on shares of Tabula Rasa HealthCare in a research note on Thursday, September 6th. They set an overweight rating and a $99.00 price target for the company. Zacks Investment Research downgraded shares of Tabula Rasa HealthCare from a buy rating to a hold rating in a research note on Tuesday, August 14th. BidaskClub downgraded shares of Tabula Rasa HealthCare from a strong-buy rating to a buy rating in a research note on Saturday, September 15th. Finally, Oppenheimer boosted their price target on shares of Tabula Rasa HealthCare from $65.00 to $86.00 and gave the stock an outperform rating in a research note on Thursday, August 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company’s stock. Tabula Rasa HealthCare presently has a consensus rating of Buy and a consensus price target of $81.60.

Shares of TRHC traded down $0.85 on Wednesday, reaching $72.96. 289,922 shares of the company’s stock were exchanged, compared to its average volume of 340,137. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.49 and a quick ratio of 0.33. The company has a market cap of $1.52 billion, a price-to-earnings ratio of -1,824.00, a price-to-earnings-growth ratio of 5.63 and a beta of 2.58. Tabula Rasa HealthCare has a 12 month low of $27.10 and a 12 month high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.19 by $0.07. The business had revenue of $54.42 million during the quarter, compared to the consensus estimate of $52.87 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. Tabula Rasa HealthCare’s revenue for the quarter was up 66.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.08 earnings per share. As a group, analysts expect that Tabula Rasa HealthCare will post 0.52 EPS for the current year.

In other Tabula Rasa HealthCare news, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, August 17th. The shares were sold at an average price of $72.23, for a total value of $577,840.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 48,000 shares of company stock valued at $3,722,960 in the last ninety days. Insiders own 14.00% of the company’s stock.

A number of large investors have recently modified their holdings of TRHC. BlackRock Inc. increased its stake in Tabula Rasa HealthCare by 29.7% in the second quarter. BlackRock Inc. now owns 2,119,507 shares of the company’s stock valued at $135,288,000 after purchasing an additional 484,979 shares in the last quarter. NN Investment Partners Holdings N.V. bought a new stake in shares of Tabula Rasa HealthCare during the second quarter worth $29,439,000. Granite Investment Partners LLC increased its position in shares of Tabula Rasa HealthCare by 1,969.2% during the second quarter. Granite Investment Partners LLC now owns 212,010 shares of the company’s stock worth $13,532,000 after acquiring an additional 201,764 shares in the last quarter. Braun Stacey Associates Inc. increased its position in shares of Tabula Rasa HealthCare by 199.0% during the second quarter. Braun Stacey Associates Inc. now owns 301,089 shares of the company’s stock worth $19,219,000 after acquiring an additional 200,394 shares in the last quarter. Finally, Jennison Associates LLC increased its position in shares of Tabula Rasa HealthCare by 29.5% during the second quarter. Jennison Associates LLC now owns 757,846 shares of the company’s stock worth $48,373,000 after acquiring an additional 172,693 shares in the last quarter. 75.88% of the stock is owned by hedge funds and other institutional investors.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Further Reading: Google Finance Portfolio Workaround

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply